The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
Abstract
With biotechnological advancements, innovative omics technologies are constantly emerging that have enabled researchers to access multi-layer information from the genome, epigenome, transcriptome, proteome, metabolome, and more. A wealth of omics technologies, including bulk and single-cell omics approaches, have empowered to characterize different molecular layers at unprecedented scale and resolution, providing a holistic view of tumor behavior. Multi-omics analysis allows systematic interrogation of various molecular information at each biological layer while posing tricky challenges regarding how to extract valuable insights from the exponentially increasing amount of multi-omics data. Therefore, efficient algorithms are needed to reduce the dimensionality of the data while simultaneously dissecting the mysteries behind the complex biological processes of cancer. Artificial intelligence has demonstrated the ability to analyze complementary multi-modal data streams within the oncology realm. The coincident development of multi-omics technologies and artificial intelligence algorithms has fuelled the development of cancer precision medicine. Here, we present state-of-the-art omics technologies and outline a roadmap of multi-omics integration analysis using an artificial intelligence strategy. The advances made using artificial intelligence-based multi-omics approaches are described, especially concerning early cancer screening, diagnosis, response assessment, and prognosis prediction. Finally, we discuss the challenges faced in multi-omics analysis, with tentative future trends in this field. With the increasing application of artificial intelligence in multi-omics analysis, we anticipate a shifting paradigm in precision medicine becoming driven by artificial intelligence-based multi-omics technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Engineering ClpS for selective and enhanced N-terminal amino acid binding
Tullman, J. A., Callahan, N., Ellington, B., Kelman, Z., & Marino, J. P. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09624-2 · Cited by 29
Recent advances in microfluidic single-cell analysis and its applications in drug development
Jiao, Y., Gao, L., Ji, Y., & Liu, W. (2022) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2022.116796 · Cited by 27
Weigelt, B., Vargas, H. A., Selenica, P., Geyer, F. C., Mazaheri, Y., Blecua, P., Conlon, N., Hoang, L. N., Jungbluth, A. A., Snyder, A., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00410 · Cited by 25
Deng, Y., Li, C., Lv, X., Xia, W., Shen, L., Jing, B., Li, B., Guo, X., Sun, Y. H., Xie, C., et al. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.106702 · Cited by 23
Versemann, L., Heßmann, E., & Ulisse, M. (2021) · Visceral Medicine · doi:10.1159/000519859 · Cited by 22
Linking imaging to omics utilizing image-guided tissue extraction
Disselhorst, J. A., Krueger, M. A., Ud-Dean, S. M. M., Bezrukov, I., Jarboui, M. A., Trautwein, C., Traube, A., Spindler, C., Cotton, J. M., Leibfritz, D., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718304115 · Cited by 21
The US Cancer Moonshot initiative
Aelion, C. M., Airhihenbuwa, C. O., Alemagno, S. A., Amler, R. W., Arnett, D. K., Balas, E. A., Bertozzi, S., Blakely, C. H., Boerwinkle, E., Brandt‐Rauf, P. W., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30054-7 · Cited by 16
Long, P., Zhang, L., Huang, B., Chen, Q., & Liu, H. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1134 · Cited by 14
Chromatin accessibility profiling methods
(2021) · Nature Reviews Methods Primers · doi:10.1038/s43586-020-00010-1 · Cited by 11
Cataloguing the proteome: Current developments in single-molecule protein sequencing
Brady, M. M., & Meyer, A. S. (2022) · Biophysics Reviews · doi:10.1063/5.0065509 · Cited by 11
Combination strategies to target metabolic flexibility in cancer
Krstić, J., Schindlmaier, K., & Prokesch, A. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.03.001 · Cited by 10
Research works printed but not linked: 8
- Anderson, 2022, Spatial transcriptomics, Cancer Cell, 40, 895, 10.1016/j.ccell.2022.08.021 · doi:10.1016/j.ccell.2022.08.021
- Linnarsson, 2016, 17, 1
- Kann, 2021, Artificial intelligence for clinical oncology, Cancer Cell, 39, 916, 10.1016/j.ccell.2021.04.002 · DOI · Paper page
- Bhinder, 2021, Artificial intelligence in cancer research and precision medicine, Cancer Discov., 11, 900, 10.1158/2159-8290.CD-21-0090 · DOI · Paper page
- Ibrahim, 2022, Assessment of mitotic activity in breast cancer: revisited in the digital pathology era, J. Clin. Pathol., 75, 365, 10.1136/jclinpath-2021-207742 · DOI
- Wang, 2020, 172, 59
- T. Guo, T. Lin, N. Antulov-Fantulin, In Exploring interpretable lstm neural networks over multi-variable data, in: International Conference on Machine Learning, PMLR, 2019, pp 2494–2504.
- Chaudhary, 2018, Deep learning-based multi-omics integration robustly predicts survival in liver cancer, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res., 24, 1248, 10.1158/1078-0432.CCR-17-0853 · DOI · Paper page
Cited by
Navigating Challenges and Opportunities in Multi-Omics Integration for Personalized Healthcare
Mohr, A. E., Ortega-Santos, C. P., Whisner, C. M., Klein-Seetharaman, J., & Jasbi, P. (2024) · Biomedicines · doi:10.3390/biomedicines12071496 · Cited by 311
“This standard workflow in ML encompasses stages like data preprocessing, algorithm and model selection, training, testing, tuning, and validation [96].”
MethodTransforming Cardiovascular Care With Artificial Intelligence: From Discovery to Practice
Khera, R., Oikonomou, E. K., Nadkarni, G. N., Morley, J. R., Wiens, J., Butte, A. J., & Topol, E. J. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.003 · Cited by 264
Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment
Zhang, C., Xu, J., Tang, R., Yang, J., Wang, W., Yu, X., & Shi, S. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01514-5 · Cited by 148
Hsu, C.-Y., Askar, S., Alshkarchy, S. S., Nayak, P. P., Attabi, K. A. L., Khan, M. A., Mayan, J. A., Sharma, M. K., Islomov, S., & Soleimani Samarkhazan, H. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01965-9 · Cited by 140
“Similarly, integrated omics classifiers have demonstrated robust diagnostic capabilities (AUC 0.81–0.87) for malignancies such as pancreatic can - cer where early detection remains challenging [ 17 , 22 ].”
InfluentialLukac, S., Dayan, D., Fink, V., Leinert, E., Hartkopf, A., Veselinovic, K., Janni, W., Rack, B., Pfister, K., Heitmeir, B., et al. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07130-5 · Cited by 130
“1 3 support establishing a more precise medicine, particularly in the days when a huge amount of data is available[17, 18].”
Background
Metadata
- Authors
- He, X., Liu, X., Zuo, F., Shi, H., & Jing, J.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 88
- Pages
- 187-200
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W4313346475
- Cited by
- 445
- References
- 211
- FWCI
- 21.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- West China Hospital, Sichuan University
- National Natural Science Foundation of China (22105137, 81902792, 82172634)
- Sichuan University (ZYYC20013)
- Shaoxing Bureau of Science and Technology (2021YFSY0007)
- National Key Research and Development Program of China (2022YFC2504700, 2022YFC2504703)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.